Objective: We have evaluated patients who were referred to the colposcopy clinic with postcoital and/or intermenstrual bleeding and suspicious looking cervix with normal smear tests (negative cytology) mainly to establish the incidence of underlying high-grade squamous intraepithelial neoplasia in these groups and also to look at our intervention rate.
Design: Retrospective study.
Setting: Colposcopy clinic in a District General Hospital in the United Kingdom.
Population: A total of 134 patients out of 812 new referrals to our colposcopy clinic during the study period were due to clinical indications only.
Results: Main indication for referral with negative cytology was post coital bleeding (47.8%). The main causes of postcoital and intermenstrual bleeding were cervical ectropions and polyps. The incidence high-grade squamous intraepithelial neoplasia (HiSIL) was 2.2% out of all the patients, which was determined after 66 biopsies.
Conclusion: In the majority of cases the pathology is benign. However the underlying prevalence of high-grade cervical disease in symptomatic women with normal smears necessitates colposcopy in selected cases. Prior assessment in the gynaecology clinic, to rule out common pathology like polyps and ectropions would reduce patient anxiety and inappropriate referrals to the clinic.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00404-007-0513-3 | DOI Listing |
AIDS Res Hum Retroviruses
January 2025
Servicio de Ginecología y Obstetricia, Hospital Universitario Torrecárdenas, GAEPI-VPH (Grupo Andaluz para el Estudio y la Prevención de la Infección por VPH), Almería, Spain.
Infection with Human immunodeficiency virus (HIV) shows a higher risk of infection by Human papillomavirus (HPV). We aim to provide evidence about the effect of a -based vaginal gel (Papilocare®) for treating HPV in women with HIV. Women ≥25 years coinfected by endocervical HPV and with low-grade abnormal cervicovaginal cytology were treated for 6 months with Papilocare® in this observational, prospective, non-controlled pilot study.
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
January 2025
Department of Women's Health, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Objective: With the transition from cytology to human papilloma virus (HPV) testing in cervical cancer screening, it is possible to use self-sampling instead of professionally collected samples. Most studies have included women between 20 and 60 years age. Here we aimed to study postmenopausal women and investigate whether vaginal self-sampling is equally effective as professional sampling for detection of HSIL and the possibility to use a method for molecular triage directly on the screening sample.
View Article and Find Full Text PDFActa Obstet Gynecol Scand
January 2025
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Introduction: Diagnostic work-up of older women with a positive cervical cancer screening test is often challenging due to incomplete visualization of the transformation zone. To reduce the risk of missing disease, a diagnostic cervical excision may be performed. However, little is known on treatment efficacy and post-treatment surveillance for older women.
View Article and Find Full Text PDFJ Cancer
January 2025
The International Peace Maternal and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030.
: This study aims to assess the immediate risk of cervical intraepithelial neoplasia grade (CIN)3+ lesions in women with abnormal cervical glandular cytology. : A total of 403 women with abnormal cervical glandular cytology who underwent simultaneous HPV genotyping and cervical biopsy at the Zhejiang University School of Medicine Women's Hospital, China, between 2016 and 2020, were included in this study. The probability of CIN3+ lesions among women in each group was further analyzed.
View Article and Find Full Text PDFAIDS Res Ther
December 2024
Jennifer Tiu, ACTG Network Coordinating Center, Bethesda, USA.
Background: Cervical cancer is a common cancer worldwide, with > 85% of deaths occurring in Lower- and Middle-Income Countries where resources for screening programs are limited. Women living with HIV (WLHIV) are at increased risk. HPV test-and-treat is a screening strategy where women with HPV are offered ablative treatment of the cervix to reduce the risk of invasive cancer.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!